Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.37 $25.53 Friday, 10th May 2024 NTLA stock ended at $24.46. This is 1.61% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.85% from a day low at $24.25 to a day high of $25.42.
90 days $19.37 $34.87
52 weeks $19.37 $47.48

Historical Intellia Therapeutics Inc prices

Date Open High Low Close Volume
Aug 30, 2023 $38.08 $38.14 $37.33 $37.96 530 441
Aug 29, 2023 $38.00 $38.72 $37.52 $38.19 847 418
Aug 28, 2023 $38.61 $38.79 $37.75 $38.01 422 325
Aug 25, 2023 $37.72 $38.70 $37.35 $38.25 586 644
Aug 24, 2023 $38.35 $38.35 $37.34 $37.52 652 652
Aug 23, 2023 $38.47 $39.01 $38.11 $38.35 563 156
Aug 22, 2023 $37.90 $38.54 $37.43 $38.26 554 412
Aug 21, 2023 $37.61 $38.27 $37.07 $37.82 633 345
Aug 18, 2023 $36.70 $38.33 $36.53 $37.59 627 176
Aug 17, 2023 $37.78 $37.78 $36.96 $37.23 582 398
Aug 16, 2023 $38.35 $38.61 $37.72 $37.75 644 796
Aug 15, 2023 $38.68 $39.07 $38.02 $38.81 673 486
Aug 14, 2023 $38.90 $39.14 $38.08 $38.92 836 627
Aug 11, 2023 $39.01 $39.93 $38.95 $39.51 477 749
Aug 10, 2023 $39.87 $40.98 $39.08 $39.55 821 913
Aug 09, 2023 $40.15 $40.57 $39.55 $40.02 786 403
Aug 08, 2023 $38.78 $40.25 $38.24 $40.01 842 623
Aug 07, 2023 $39.60 $39.91 $38.73 $39.02 845 191
Aug 04, 2023 $39.56 $40.50 $39.26 $39.61 929 003
Aug 03, 2023 $38.33 $39.38 $38.05 $39.09 1 278 361
Aug 02, 2023 $40.00 $40.27 $39.01 $39.71 1 100 149
Aug 01, 2023 $41.49 $41.55 $40.36 $40.96 715 188
Jul 31, 2023 $42.33 $43.06 $41.91 $42.33 452 914
Jul 28, 2023 $41.61 $42.83 $41.59 $42.36 587 884
Jul 27, 2023 $42.74 $42.84 $40.64 $40.97 793 477
Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT